This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nehyba, J Articles by Humphries, E H Search for Related Content PubMed PubMed Citation Articles by Nehyba, J Articles by Humphries, E H

Next Article 

J Virol. 1994 April; 68(4): 2039-2050

Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation.

Mary Babb Randolph Cancer Center, West Virginia University, Morgantown 26506-9300.

ABSTRACT

v-rel is a viral oncogene that evolved from turkey c-rel, an NF-kappa B-related transcription factor. Numerous structural alterations record the evolutionary selection of v-rel and distinguish it from c-rel. To evaluate the biological significance of these alterations, we constructed a set of five c/v-rel hybrids in which three mutation clusters (c-Rel amino acids 1 to 97,222 to 302, and 328 to 598) were differentially distributed. These constructs, in addition to parental v-rel and c-rel and two C-terminal deletion mutants of c-rel, were expressed from a retroviral vector. An analysis of cells infected with each of the nine viruses revealed that mutations in all three domains contributed to the ability of v-rel to induce two endogenous c-rel target genes, major histocompatibility complex (MHC) class I and class II, in the B-cell line DT95 as well as MHC class II in normal splenocytes. The analysis revealed a strong nonlinear correlation between the ability of a Rel protein to induce expression of MHC proteins and its capacity to produce splenic tumors and establish in vitro transformation. This correlation is consistent with the hypothesis that v-rel transforms by constitutively altering expression of genes regulated by c-rel and in this way simulates events associated with immune response-linked proliferation of cells of hematopoietic origin. Further, the 16 carboxy-terminal amino acids of c-Rel were identified as a domain responsible for producing a cytotoxic and/or cytostatic effect in DT95. Because this effect is likely to differentially influence induction of MHC expression and tumorigenesis/transformation, it may represent one factor that contributes to the nonlinearity of their correlation.

This article has been cited by other articles:

• Gupta, N., Delrow, J., Drawid, A., Sengupta, A. M., Fan, G., Gelinas, C. (2008). Repression of B-Cell Linker (BLNK) and B-Cell Adaptor for Phosphoinositide 3-Kinase (BCAP) Is Important for Lymphocyte Transformation by Rel Proteins. Cancer Res. 68: 808-814 [Abstract] [Full Text]  
• Hrdlickova, R., Nehyba, J., Liss, A. S., Bose, H. R. Jr. (2006). Mechanism of Telomerase Activation by v-Rel and Its Contribution to Transformation. J. Virol. 80: 281-295 [Abstract] [Full Text]  
• Nehyba, J., Hrdlickova, R., Burnside, J., Bose, H. R. Jr. (2002). A Novel Interferon Regulatory Factor (IRF), IRF-10, Has a Unique Role in Immune Defense and Is Induced by the v-Rel Oncoprotein. Mol. Cell. Biol. 22: 3942-3957 [Abstract] [Full Text]  
• Liss, A. S., Bose, H. R. Jr. (2002). Mutational Analysis of the v-Rel Dimerization Interface Reveals a Critical Role for v-Rel Homodimers in Transformation. J. Virol. 76: 4928-4939 [Abstract] [Full Text]  
• Bose, H. R. Jr. (2001). Interferon Regulatory Factor 4 Contributes to Transformation of v-Rel-Expressing Fibroblasts. Mol. Cell. Biol. 21: 6369-6386 [Abstract] [Full Text]  
• Chen, E., Hrdlickova, R., Nehyba, J., Longo, D. L., Bose Jr., H. R., Li, C.-C. H. (1998). Degradation of Proto-oncoprotein c-Rel by the Ubiquitin-Proteasome Pathway. J. Biol. Chem. 273: 35201-35207 [Abstract] [Full Text]